Earnings Call · Q3 FY2023·2023-11-06

Q3 23EPS +27.27%·Rev n/aQ2 23EPS +61.54%·Rev n/aQ1 23EPS +17.65%·Rev n/aQ4 22EPS +34.62%·Rev n/a⚠ consensus missing

CLOVER HEALTH INVESTMENTS, CORP. /DE CLOV

Ryan Schmidt — Investor Relations or Communications

Andrew Toy — Chief Executive Officer

Scott Leffler — Chief Financial Officer

−18.2%1d on move date−18.5% vs SPY3d−21.9%5d−20.4%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more CLOV calls or request research access.

More CLOV calls Browse calls Request research access